 Fibrin formation vessel walls hyperplastic malignant prostate tissue mechanisms coagulation activation adenocarcinoma prostate occurrence distribution components coagulation fibrinolysis pathways situ means immunohistochemical techniques frozen sections fresh malignant benign hyperplastic prostatic tissue transurethral resection Fibrinogen perivascular tumor connective tissue malignant benign disease present adjacent areas normal prostate Antibodies fibrin D-dimer sites vascular endothelium malignant benign tissues neoplastic cells benign hyperplastic glandular epithelial cells weakly patchy distribution tissue factor low-molecular-weight urokinase-type plasminogen activator Focal staining vascular endothelium tissue plasminogen activator plasmin-antiplasmin complex neoantigen contrast tissue staining factor VII factor factor XIII subunit high-molecular-weight urokinase-type plasminogen activator plasminogen activator inhibitors protein Thus similarity findings benign hyperplastic neoplastic prostate tissue lack intact tumor cell-associated coagulation pathway fibrin formation presence fibrin vascular endothelium consistent concept coagulation activation prostatic cancer due direct effect tumor cells clotting mechanism activation soluble tumor product procoagulant activity certain host example vascular endothelial cells findings lack effect warfarin anticoagulation clinical course patients prostatic cancer contrast findings certain tumor types coagulation activation progression adenocarcinoma prostate